Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>

Omicron病毒全球肆虐 惟本港上市疫苗生物股隨外圍同業捱沽

缸邊情報 ·  {{timeTz}}

Omicron新冠變種病毒於全球肆虐,其中美國確診病例創紀錄高,導致美國數以千計學校推遲返校或轉為遠程學習。而美國食品藥物管理局(FDA)授權12至15歲兒童接種輝瑞(PFE.US)和BioNTech(BNTX.US)提供第三劑新冠疫苗,BioNTech股價隔晚(3日)挫10.1%收231.85美元,但輝瑞昨晚逆市挫逾4%收56.65美元;另一隻疫苗股莫德納(MRNA.US)更挫7.5%收235.05美元。

於本港上市疫苗和生物股今天也普遍下挫,尤其是康希諾生物-B(06185.HK)一舉破20天、50天及10天線(167.7-175.4元),最低見159元,現報160元,急挫10.7%。信達生物(01801.HK)連挫兩天屢尋底,今天低見39.7元,創逾年半低,現報40元,續挫9.2%。開拓藥業-B(09939.HK)低見12.12元,現報12.26元,挫8.1%

藍籌藥明生物(02269.HK)繼昨天一舉跌破10天及20天線後,今天進一步低見79.1元,現報81.7元,續挫6.3%;其母企藥明康德(02359.HK)也連挫兩天,股價繼昨天失守10天線後,今天低116.1元,創逾九個月低,現報117.7元,續挫6.1%。

騰盛博藥-B(02137.HK)最低見27.85元,現報28.85元,續挫8.8%。復星醫藥(02196.HK)最低見32.4元,現報32.45元,續跌3.3%。康方生物-B(09926.HK)最低見27.8元,屢創逾一年低,現報28.5元,續跌6.3%;康寧傑瑞製藥-B(09966.HK)低見12.42元,現報12.64元,反覆續跌4.8%。百濟神州(06160.HK)低見152.1元,現報152.3元,續挫4.9%。

此外,歌禮製藥-B(01672.HK)公布全資附屬自主研發治療非酒精性脂肪性肝炎藥物完成美國I期臨床試驗。該股繼昨天急漲32%後,今早進一步升至4.61元創近兩年高遇阻,掉頭低見3.81元,現報4.28元,倒跌1.6%。

This page is machine-translated. Futubull tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.

Back to the Top